Figure legend.
Figure 1. A. MRI in the acute onset of cerebral
dysfunction demonstrated a focal area of hyperintensity in the right
centrum semiovale with diffusion restriction (white arrow). B.48 hours after, MRI revealed no more lessions and showed more clearly a
focal white matter hyperintensity with diffusion restriction (white
arrow).
References
1. Watanabe K, Arakawa Y, Oguma E, et al. Characteristics of
methotrexate-induced stroke-like neurotoxicity. International
journal of hematology. 2018;108(6):630-636.
2. Millan NC, Pastrana A, Guitter MR, Zubizarreta PA, Monges MS, Felice
MS. Acute and sub-acute neurological toxicity in children treated for
acute lymphoblastic leukemia. Leukemia research. 2018;65:86-93.
3. Bhojwani D, Sabin ND, Pei D, et al. Methotrexate-induced
neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic
leukemia. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2014;32(9):949-959.
4. Cruz-Carreras MT, Chaftari P, Shamsnia A, Guha-Thakurta N, Gonzalez
C. Methotrexate-induced leukoencephalopathy presenting as stroke in the
emergency department. Clinical case reports.2017;5(10):1644-1648.
5. Rogers P, Pan WJ, Drachtman RA, Haines C. A Stroke Mimic:
Methotrexate-induced Neurotoxicity in the Emergency Department.The Journal of emergency medicine. 2017;52(4):559-561.
6. Iwatani K, Fujii N, Deguchi S, Tanimoto M. Subacute
methotrexate-related leukoencephalopathy with stroke-like presentation.International journal of hematology. 2012;96(6):683-684.
7. Bond J, Hough R, Moppett J, Vora A, Mitchell C, Goulden N.
’Stroke-like syndrome’ caused by intrathecal methotrexate in patients
treated during the UKALL 2003 trial. Leukemia.2013;27(4):954-956.
8. Valle DA, Kakehasi FM, Melo RM, Siqueira CM, Soares TF, Rodrigues KE.
Stroke-like encephalopathy following high-dose intravenous methotrexate
in an adolescent with osteosarcoma: a case report. Revista
brasileira de hematologia e hemoterapia. 2016;38(4):364-367.
9. Afshar M, Birnbaum D, Golden C. Review of dextromethorphan
administration in 18 patients with subacute methotrexate central nervous
system toxicity. Pediatric neurology. 2014;50(6):625-629.
10. Vijayanathan V, Gulinello M, Ali N, Cole PD. Persistent cognitive
deficits, induced by intrathecal methotrexate, are associated with
elevated CSF concentrations of excitotoxic glutamate analogs and can be
reversed by an NMDA antagonist. Behavioural brain research.2011;225(2):491-497.